|
|
|
Volumn 6, Issue 2, 2013, Pages 100-
|
|
Drug combination extends late-stage pancreatic cancer survival in Phase III clinical trial.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
130 NM ALBUMIN BOUND PACLITAXEL;
130-NM ALBUMIN-BOUND PACLITAXEL;
ALBUMINOID;
ANTINEOPLASTIC AGENT;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
PACLITAXEL;
HUMAN;
MORTALITY;
NOTE;
PANCREAS TUMOR;
PHASE 3 CLINICAL TRIAL (TOPIC);
SURVIVAL RATE;
TREATMENT OUTCOME;
ALBUMINS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS, PHASE III AS TOPIC;
DEOXYCYTIDINE;
HUMANS;
PACLITAXEL;
PANCREATIC NEOPLASMS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 84883760390
PISSN: None
EISSN: 17512441
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
